ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,934, issued on March 24, was assigned to ADIENNE S.A. (Lugano, Switzerland).
"Anti-CD26 antibodies and uses thereof" was invented by Antonio Francesco Di Naro (Morcote, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention pertains to novel antibodies capable of binding to CD26, as well as to their use as a medicament. Moreover, the present invention provides antibodies for use in treating and/or preventing Graft-versus-Host Disease (GvHD), for use in treating Aplastic Anemia and/or for use in promoting engraftment after haematopoietic stem cell transplantation. Furthermore, the present invention provides pharmaceutical c...